Literature DB >> 12780557

Humoral theory of transplantation.

Paul I Terasaki1.   

Abstract

According to the humoral theory of transplantation, antibodies cause allograft rejection. Publications are cited showing that antibodies: (1). cause hyperacute kidney rejection, (2). lead to C4d deposits associated with early kidney graft failures, (3). are a good indicator of presensitization leading to early acute rejections, (4). were present in 96% of 826 patients who rejected a kidney graft, (5). are associated with chronic rejection in 33 studies of kidney, heart, lung and liver grafts, and (6). in three studies, appeared in the circulation BEFORE evidence of bronchiolitis obliterans in lung transplants, and BEFORE kidney rejection. In addition, a prospective cooperative study of 1629 patients in 24 centers demonstrated that antibodies foretold subsequent failures after a follow-up period of 6 months (p = 0.05). The specificity of antibodies detected in the serum of rejecting patients were often not donor specific, presumably because they were absorbed by the rejecting organ. If the humoral theory is accepted, even provisionally, transplanted patients who have antibodies could be treated with immunosuppression until the antibodies disappear to determine whether chronic rejection can be blocked. If successful, in patients who do not have antibodies, immunosuppression could be reduced until antibodies appear.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780557     DOI: 10.1034/j.1600-6143.2003.00135.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  99 in total

Review 1.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

2.  Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.

Authors:  Fabrice Porcheray; Julie DeVito; Beow Y Yeap; Lijuan Xue; Ian Dargon; Rosemary Paine; Timothy C Girouard; Susan L Saidman; Robert B Colvin; Waichi Wong; Emmanuel Zorn
Journal:  Transplantation       Date:  2010-05-27       Impact factor: 4.939

3.  Prevention trumps treatment of antibody-mediated transplant rejection.

Authors:  Stuart J Knechtle; Jean Kwun; Neal Iwakoshi
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 4.  [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection].

Authors:  Helmut E Feucht
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

Review 5.  [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions].

Authors:  Georg Böhmig
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

Review 6.  HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.

Authors:  Adriana Zeevi; Alin Girnita; Rene Duquesnoy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  Noncognate function of B cells in transplantation.

Authors:  Samuel J Balin; Jeffrey L Platt; Marilia Cascalho
Journal:  Transpl Int       Date:  2009-01-16       Impact factor: 3.782

8.  Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient.

Authors:  Priya Verghese; Stephen Darrow; Margaret H Kurth; Robyn C Reed; Youngki Kim; Susan Kearney
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

9.  Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.

Authors:  Y-P Jin; N M Valenzuela; M E Ziegler; E Rozengurt; E F Reed
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

10.  Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.

Authors:  Hamid Khan; Muhammed Mubarak; Tahir Aziz; Ejaz Ahmed; Syed Fazal Akhter; Javed Kazi; Syed Aa Naqvi; Syed Ah Rizvi
Journal:  J Nephropathol       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.